Extracorporeal photopheresis and renal transplantation

Extracorporeal photopheresis and renal transplantation

Bibliographic Details
Main Authors:	Saulo Fernández Granados, Ernesto Fernández Tagarro, Ana Ramírez Puga, Rita Guerra Rodríguez, Ingrid Auyanet Saavedra, Saavedra González Nuez, César García-Cantón, Fernando Fernández Fuertes, Manuel Tapia Martín
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Nefrología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251420301516

Similar Items

Extracorporeal photopheresis in solid organ transplantation
by: A. V. Kildyushevsky, et al.
Published: (2020-10-01)

Extracorporeal Photopheresis in Dermatological Diseases
by: Hanna Terhaar, et al.
Published: (2024-03-01)

Fotoferese extracorpórea Extracorporeal photopheresis
by: Márcia M. Silva, et al.
Published: (2008-04-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

Extracorporeal photopheresis: Review of technical aspects
by: Satyam Arora, et al.
Published: (2017-01-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
by: Maja-Theresa Dieterlen, et al.
Published: (2021-08-01)

OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
by: Giancarlo Fatobene, et al.
Published: (2022-07-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? : Beyond Current Dogma
by: Dalil eHannani
Published: (2015-07-01)

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease
by: Adrian Peacock, et al.
Published: (2024-02-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
by: Nadia Ninosu, et al.
Published: (2023-12-01)

Extracorporeal photopheresis in chronic graft-versus-host disease: clinical description and economic study
by: Dora Fraga Vargas, et al.
Published: (2023-04-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
by: Ines Bojanic, et al.
Published: (2023-02-01)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

Extracorporeal photopheresis in the treatment of the novel coronavirus disease COVID-19 (a case series)
by: A. V. Kildyushevsky, et al.
Published: (2020-09-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
by: Thilo Gambichler, et al.
Published: (2022-05-01)

Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis
by: Valeria Behle, et al.
Published: (2017-05-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Roberto Crocchiolo, et al.
Published: (2021-03-01)

A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
by: Marie Laulhé, et al.
Published: (2019-01-01)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)

Papel de la fotoaféresis en el tratamiento del rechazo celular agudo refractario en trasplante renal
by: Ernesto José Fernández, et al.
Published: (2016-05-01)

Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection
by: Arnaud Lionet, MD, et al.
Published: (2024-03-01)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024-03-01)

Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs
by: Sara Bozzini, et al.
Published: (2022-03-01)

Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010–2015
by: You-Li Ling, et al.
Published: (2020-01-01)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)